2020

27-Oct

Heritas-backed Hummingbird Biosciences Received HSA Authorization to Initiate Clinical Trial Study for COVID-19 Antibody Treatment

2020

17-Oct

Heritas' Majority-Owned Portfolio Company, Timberland Medical Centre, Announced Development of New Hospital in Kuching,

Sarawak

2020

7-Aug

AIA Agrees Exclusive Asia-Pacific Regional Partnership with Heritas-backed Holmusk

2020

22-Jun

SilverConnect closes seed round financing led by Heritas Capital and SEEDS Capital to launch Dysphagia-friendly meals online and in nursing homes

2020

18-May

Heritas-backed Holmusk announces US$21.5 million series A

financing led by Optum Ventures and Health Catalyst Capital

2020

11-May

Hummingbird Bioscience closes US$25M investment with Series B extension

2019

5-Dec

Hummingbird Biosciences, backed by Heritas and Seeds Capital, announces US$19m in Series B Financing led by Mirae and GNTech

2019

16-Oct

Heritas completed investment into leading healthcare start-up in Indonesia

2019

16-Jul

Hummingbird Bioscience closes extended Series A financing to advance clinical pipeline

2019

13-Mar

CXA raises US$25m to accelerate expansion across Asia-Pacific

2019

3-Jan

Heritas completed investment into Gorry Holdings, a leading nutrition & wellness tech platform in Indonesia

2018

26-Sep

Alchemy FoodTech secures seven-digit investment first close in pre-series A financing

2018

Holmusk raises US$9.75 million in Pre-Series A financing

25-Sep

2018

Heritas Capital Management appointed by SPRING SEEDS Capital as co-investment partner under Startup SG Equity

9-Feb

2018

Strand Life Sciences closes financing led By Quadria Capital

8-Feb

2017

20-Dec

Heritas invests in Tessa Therapeutics, a leading biopharmaceutical company focusing on T Cell Therapy